Article
Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 in <i>Plasmodium falciparum</i>
2022-12-11
Abstract excerpt
Malaria drug resistance is hampering the fight against the deadliest parasitic disease affecting over 200 million people worldwide. We recently developed quinoline-quinazoline-based inhibitors (as compound 70 ) as promising new antimalarials. Here we aimed to investigate their mechanism of action by using Thermal Proteome Profiling (TPP). The eukaryotic translation initiation factor 3 (EIF3i) subunit I was identi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db0b3204-4b53-592a-b0bf-7908a334fdab
- DOI
- 10.1101/2022.12.10.519887
